The US Food and Drug Administration (FDA) announced today it had scheduled a meeting of the Center for Biologics Evaluation and Research (CBER) to convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
During this meeting on June 10, 2021, the FDA will provide a status update on its approach to Emergency Use Authorization (EUA) for COVID-19 vaccines intended for use in individuals 12 through 17 years of age.
COVID-19 Vaccines Potentially Authorized for Children
US Funds $250 Million to Create New Vaccination Workforce
The U.S. Department of Health and Human Services (HHS) recently announced the availability of approximately $250 million to develop and support a community-based vaccination workforce.
Announced on May 4, 2021, this new workforce will serve as trusted voices sharing information about vaccines, increase COVID-19 vaccine confidence, and address any barriers to vaccination for individuals living in vulnerable and medically underserved communities.
Cardiopulmonary exercise testing during the COVID-19 pandemic.
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has presented a global public health emergency. Although predominantly a pandemic of acute respiratory disease, corona virus […]
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
“Re-infection” with COVID-19 is a growing concern; re-infection cases have reported worldwide. However, the clinical characteristics of SARS-CoV-2 re-infection, including the levels and role of anti-SARS-CoV-2 Spike protein IgG antibodies […]
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
The innate immune response is critical for recognizing and controlling infections through the release of cytokines and chemokines. However, severe pathology during some infections, including SARS-CoV-2, is driven by hyperactive […]
Psychological distress and burden among family caregivers of children with and without developmental disabilities six months into the COVID-19 pandemic.
The COVID-19 pandemic has created unique challenges for family caregivers of children with developmental disabilities (DD). The purpose of this study was to conduct a 6-month follow-up on the experiences […]
Use of virtual reality in the inpatient rehabilitation of COVID-19 patients.
Use of virtual reality (VR) in healthcare has expanded in recent years. The challenges faced by patients with prolonged COVID-19-related hospitalizations – social isolation, disability, neurologic sequelae, adjustment-related anxiety, depression, […]
A global public health convention for the 21st century.
As shown by COVID-19, infectious diseases with a pandemic potential present a grave threat to health and wellbeing. Although the International Health Regulations provide a framework of binding legal obligations […]
Associations of acute exposure to airborne pollutants with COVID-19 infection: evidence from China.
The outbreak of COVID-19, caused by SARS-CoV-2, has spread across many countries globally. Greatly, there are limited studies concerned with the effect of airborne pollutants on COVID-19 infection, while exposure […]
Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer.
To analyse the impact of the COVID-19 pandemic on a centralised specialist kidney cancer care pathway.Retrospective analysis of patient and pathway characteristics including prioritisation strategies at the Specialist Centre for […]